FDA Approves Maxigesic IV to be Marketed in the U.S. as Combogesic IV (acetaminophen and ibuprofen) for the Management of Pain

Maxigesic® IV, a potent non-opioid painkiller, to be marketed in the U.S. under the tradename Combogesic® IV Liège, Belgium– 18 OCTOBER 2023 - Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news